Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award SVP, CFO and Treasurer acquired 200,000 shares (grant or award)
  2. 4 Grant or award Director acquired 13,700 shares (grant or award)
  3. 4 Grant or award Director acquired 13,700 shares (grant or award)
  4. 4 Grant or award Director acquired 13,700 shares (grant or award)
  5. 4 Grant or award Director acquired 13,700 shares (grant or award)
  6. 4 Grant or award Director acquired 13,700 shares (grant or award)
  7. 4 Grant or award Director acquired 13,700 shares (grant or award)
  8. 4 Grant or award Director acquired 13,700 shares (grant or award)
  9. 4 Open-market sale Director sold 4,567 shares at $0.36 ($1,653)
  10. 4 Grant or award SVP, Chief Medical Officer acquired 200,000 shares (grant or award)
  11. 4 Grant or award SVP, Chief Accounting Officer acquired 150,000 shares (grant or award)
  12. 4 Open-market sale CEO and President sold 79,026 shares at an average $2.17 ($171,143)
  13. 4 Open-market sale SVP, Chief Medical Officer sold 15,056 shares at an average $2.16 ($32,564)
  14. 4 Open-market sale SVP, Chief Accounting Officer sold 3,946 shares at $2.15 ($8,503)
  15. 4 Open-market sale SVP, Chief Operating Officer sold 21,533 shares at an average $2.17 ($46,637)
  16. 4 Open-market sale SVP, CCO sold 13,184 shares at an average $2.16 ($28,515)
  17. 4 Open-market sale SVP, Chief Legal Officer sold 21,062 shares at an average $2.17 ($45,615)
  18. 4 Open-market sale SVP, CFO and Treasurer sold 8,203 shares at an average $2.16 ($17,689)
  19. 4/A Other acquisition CEO and President acquired 1,248 shares (other)
  20. 4 Open-market sale SVP, Chief Accounting Officer sold 5,833 shares at $2.29 ($13,335)

Page 6 of 19 · 378 filings